Streetbeat News

Earnings

HUM

Humana has increased its forecast for 2024 Individual Medicare Advantage membership growth by 50,000, now expecting an annual increase of 150,000 members, or 2.8%. This adjustment reflects the company's positive outlook on its ability to attract and retain members in the competitive Medicare Advantage market.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:36 am

BSX

Boston Scientific has updated its net sales growth forecast for 2024, projecting an increase of 11%-13% on a reported basis and 10%-12% on an organic basis. This is a significant improvement from the previously guided ranges of approximately 8.5%-9.5% and 8%-9%, respectively.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:36 am

T

AT&T has reaffirmed its 2024 financial outlook, projecting adjusted earnings per share (EPS) in the range of $2.15 to $2.25, which is higher than the estimated $2.07. This update underscores the company's confidence in its future financial performance.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:35 am

HUM

Humana has reaffirmed its FY24 adjusted EPS outlook at approximately $16.00, against analysts' expectations of $16.36. However, it revised its FY 2024 EPS guidance on a GAAP basis to approximately $13.93 from the previously stated $14.87.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:34 am

HAS

Hasbro (NASDAQ:HAS) reported Q1 adjusted earnings of $0.61 per share, surpassing the $0.27 estimate, marking a 125.93% beat and a 6000% increase from last year's $0.01. Q1 sales reached $757.30M, exceeding the $738.61M estimate by 2.53%, despite a 24.35% decrease from last year's $1.00B.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:34 am

T

AT&T reported a Q1 free cash flow of $3.1 billion, marking an increase of $2.1 billion from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:34 am

T

AT&T reported its Q1 2024 Non-GAAP EPS at $0.55, surpassing the estimated $0.54. This indicates a positive performance against market expectations.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:33 am

NAVI

Navient (NASDAQ:NAVI) reported Q1 adjusted earnings of $0.47 per share, missing the consensus estimate of $0.58, and sales of $152M, below the expected $179M. This represents a significant decrease from the previous year's earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:32 am

BSX

Boston Scientific (NYSE:BSX) reported Q1 2024 adjusted EPS of $0.56, surpassing the $0.51 estimate, and sales of $3.856B, exceeding the $3.685B estimate. This represents a 19.15% increase in earnings and a 13.78% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:32 am

HUM

Humana (NYSE:HUM) reported Q1 2024 adjusted earnings of $7.23 per share, surpassing the consensus estimate of $6.12 by 18.14%. Adjusted sales reached $29.332 billion, exceeding estimates of $28.473 billion by 3.02% and marking a 14.35% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:32 am